History

    
1950
  • Hitachi Chemical Co., Ltd. (as Chemiphar was formerly known) is set up
1951
  • Hatagaya Factory opens in Shibuya-ku, Tokyo
1957
  • Starts importing pharmaceuticals from Italy
  • Main office moves to Bunkyo-ku Tokyo
1960
  • Soka Factory opens in Misato City, Saitama Prefecture
1969
  • Nihon Pharmaceutical Industry Co., Ltd. (NPI) becomes an affiliated company
1970
  • Company changes name to Nippon Chemiphar Co., Ltd.
1971
  • Listed on Tokyo Stock Exchange (Second Section)
1973
  • Sets up R&D facility in Soka Factory
1975
  • Head office moved to Chiyoda-ku, Tokyo
1976
  • Listed on Tokyo Stock Exchange (First Section)
  • Starts diagnostics business
  • Establishes Japan Sopharchim Co., Ltd. (currently an affiliated company)
1977
  • Establishes Ibaraki Factory in Makabe-gun, Ibaraki Prefecture (NPI's current Tsukuba Factory)
1983
  • Establishes Shapro Inc., enters cosmetics and health-food market
1986
  • Safety Research Institute for Chemical Compounds Co., Ltd. becomes a subsidiary
1988
  • Launches Uralyt-U (soluble powder)
1993
  • Launches Soleton Tab. 80
1995
  • Launches Calvan Tab.
2000
  • Strengthens focus on generics business
2001
  • Launches DP2000 and Oriton IgE NC
2002
  • Concludes comprehensive business alliance concluded with Ranbaxy Laboratories Limited in India
2004
  • Concludes business alliance with Nihon Chouzai Co., Ltd.
2005
  • PPAR delta agonist and NC-2300 are licensed out to overseas venture companies
  • A subsidiary company, NPI, becomes 50:50 joint venture of Chemiphar and Ranbaxy
2009
  • Dissolves the comprehensive business alliance with Ranbaxy. NPI becomes a subsidiary again.
2010
  • NPI becomes a wholly owned Chemiphar subsidiary;.Chemiphar spins off its Ibaraki Factory to NPI.
  • Termination of business alliance with Nihon Chouzai Co., Ltd.
2012
  • Launches DP3000.
2014
  • New plant at NPI's Tsukuba factory comes on line.
2015
  • Establishes Nippon Chemiphar Vietnam Co., Ltd.
2017
  • NC-VN completes construction of a new plant in Binh Duang Province,Vietnam.
  • Establishes West Japan Distribution Center, creating one base each for in East and West Japan.
2018
  • NC-VN Vietnam factory starts export to Japan.
2019
  • Acquires approval for the manufacture and sale of PICOPREP from Ferring Pharmaceuticals Co., Ltd.
2020
  • Launches DropScreen™
  • Concluded a license agreement with Delta-Fly Pharma, Inc. for DFP-17729.
  • Acquires sales rights for Klaricid from Mylan EPD G.K.
  • Delta-Fly Pharma starts phase 1 clinical trials of DFP-17729 for pancreatic cancer.
2021
  • DFP-17729 has moved to Phase 2a trial.
  • Concluded a collaborative research and development agreement and an option agreement for NC-2800 with Sumitomo Dainippon Pharma Co., Ltd. and began phase 1 trials in July.
2022
  • Concluded a license agreement with Delta-Fly Pharma for DFP-14323.
2023
  • Nanjing Neiwa Faith and Chemiphar conclude license agreement for NC-2500 in China.
Related Information
PageTop